TABUTEAU HERRIOT Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
3
Insider Sells Sum
$7.36M

Insider Activity of TABUTEAU HERRIOT

According to the SEC Form 4 filings, TABUTEAU HERRIOT, being in a position of

  1. Chief Executive Officer at Axsome Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 473031 share for $85.67M,
    over all time since 2025-09-12, has bought 0 shares, and sold 673000 shares for $110.58M.

Biography of TABUTEAU HERRIOT

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $85,666,45313100

Comparison of Insiders on Amount of Buys and Sells

2026-08-06SaleAxsome Therapeutics, Inc.
AXSM
Chief Executive Officer
4,660
0.0092%
$213.95$997,007-5.41%
2026-08-05SaleAxsome Therapeutics, Inc.
AXSM
Chief Executive Officer
45,004
0.0871%
$212.01$9.54M-6.5%
2026-07-01SaleAxsome Therapeutics, Inc.
AXSM
Chief Executive Officer
49,666
0.0947%
$240.25$11.93M-13.65%
2026-06-09SaleAxsome Therapeutics, Inc.
AXSM
Chief Executive Officer
49,670
0.0989%
$241.01$11.97M-13.88%
2026-02-02SaleAxsome Therapeutics, Inc.
AXSM
Chief Executive Officer
32,410
0.0642%
$185.60$6.02M+10.14%
2026-01-07SaleAxsome Therapeutics, Inc.
AXSM
Chief Executive Officer
31,261
0.0619%
$170.38$5.33M+13.33%
2026-01-06SaleAxsome Therapeutics, Inc.
AXSM
Chief Executive Officer
29,450
0.0587%
$172.33$5.08M+11.28%
2026-01-05SaleAxsome Therapeutics, Inc.
AXSM
Chief Executive Officer
78,703
0.1559%
$171.28$13.48M+10.27%
2025-12-04SaleAxsome Therapeutics, Inc.
AXSM
Chief Executive Officer
10,558
0.021%
$148.18$1.56M+25.74%
2025-12-03SaleAxsome Therapeutics, Inc.
AXSM
Chief Executive Officer
20,163
0.0398%
$146.94$2.96M+25.87%
2025-12-02SaleAxsome Therapeutics, Inc.
AXSM
Chief Executive Officer
49,252
0.0994%
$144.59$7.12M+30.87%
2025-11-05SaleAxsome Therapeutics, Inc.
AXSM
Chief Executive Officer
21,775
0.0435%
$134.49$2.93M+35.97%
2025-11-04SaleAxsome Therapeutics, Inc.
AXSM
Chief Executive Officer
50,459
0.1002%
$133.79$6.75M+36.7%
2025-11-03SaleAxsome Therapeutics, Inc.
AXSM
Chief Executive Officer
91,705
0.1802%
$132.34$12.14M+35.83%
2025-10-08SaleAxsome Therapeutics, Inc.
AXSM
Chief Executive Officer
12,774
0.0256%
$118.84$1.52M+55.33%
2025-10-07SaleAxsome Therapeutics, Inc.
AXSM
Chief Executive Officer
13,390
0.0269%
$118.77$1.59M+55.42%
2025-10-06SaleAxsome Therapeutics, Inc.
AXSM
Chief Executive Officer
19,220
0.0386%
$120.17$2.31M+53.74%
2025-09-16SaleAxsome Therapeutics, Inc.
AXSM
Chief Executive Officer
19,719
0.0395%
$114.19$2.25M+60.36%
2025-09-15SaleAxsome Therapeutics, Inc.
AXSM
Chief Executive Officer
15,254
0.0307%
$117.37$1.79M+56.65%
2025-09-12SaleAxsome Therapeutics, Inc.
AXSM
Chief Executive Officer
27,907
0.0562%
$118.96$3.32M+54.26%
Total: 20
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.